Documentation Centre

 

 

  of 562 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification. Am Heart J. 2017;193:95-103 February 20, 2018 Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification. Am Heart J. 2017;193:95-103 Akintoye E, Briasoulis A, Afonso L Key Publications
Inflammation and atherosclerosis: The end of a controversy. Circulation. 2017;136:1875-1877 February 20, 2018 Inflammation and atherosclerosis: The end of a controversy. Circulation. 2017;136:1875-1877 Hansson GK Key Publications
Factors regulating subcutaneous adipose tissue storage, fibrosis, and inflammation may underlie low fatty acid mobilization in insulin-sensitive obese adults. Am J Physiol Endocrinol Metab. 2017;313:E429-E439 February 09, 2018 Factors regulating subcutaneous adipose tissue storage, fibrosis, and inflammation may underlie low fatty acid mobilization in insulin-sensitive obese adults. Am J Physiol Endocrinol Metab. 2017;313:E429-E439 Van Pelt DW, Guth LM, Wang AY, Horowitz JF Key Publications
High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction. Atherosclerosis. 2017;266:16-23 February 08, 2018 High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction. Atherosclerosis. 2017;266:16-23 Pokharel Y, Sharma PP, Qintar M, Lu Y, Tang Y, Jones P, Dreyer RP, Spertus JA Key Publications
Increased inflammatory effect of electronegative LDL and decreased protection by HDL in type 2 diabetic patients. Atherosclerosis. 2017;265:292-298 December 07, 2017 Increased inflammatory effect of electronegative LDL and decreased protection by HDL in type 2 diabetic patients. Atherosclerosis. 2017;265:292-298 Estruch M, Miñambres I, Sanchez-Quesada JL, Soler M, Pérez A, Ordoñez-Llanos J, Benitez S Key Publications
Anti-inflammatory effects of active commuting and leisure time exercise in overweight and obese women and men: A randomized controlled trial. Atherosclerosis. 2017;265:318-324 December 07, 2017 Anti-inflammatory effects of active commuting and leisure time exercise in overweight and obese women and men: A randomized controlled trial. Atherosclerosis. 2017;265:318-324 Gram AS, Bladbjerg EM, Quist JS, Petersen MB, Rosenkilde M, Stallknecht B. Key Publications
Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119-1131 December 05, 2017 Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119-1131 Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al. Key Publications
Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377:1197-1198 December 05, 2017 Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377:1197-1198 Harrington RA Key Publications
Imaging: Perivascular fat - an unheralded informant of coronary inflammation. Nat Rev Cardiol. 2017;14:573-574 November 28, 2017 Imaging: Perivascular fat - an unheralded informant of coronary inflammation. Nat Rev Cardiol. 2017;14:573-574 Dweck MR, Fayad ZA Key Publications
C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study. Atherosclerosis. 2017;263:293-300 November 23, 2017 C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study. Atherosclerosis. 2017;263:293-300 Eltoft A, Arntzen KA, Hansen JB, Wilsgaard T, Mathiesen EB, Johnsen SH Key Publications

  of 562 Next page

Go to page: of